Seagate (STX) Form 144 Filed for 750-Share Sale via Morgan Stanley

Rhea-AI Filing Summary

Seagate Technology Holdings PLC (STX) Form 144 reports a proposed sale of 750 shares of common stock through Morgan Stanley Smith Barney for an aggregate market value of $125,550, with an approximate sale date of 09/02/2025 on Nasdaq. The filer indicates the shares were acquired as Restricted Stock Units on 10/23/2023 from the issuer and that no sales by the same person occurred in the past three months. The notice includes the standard representation that the seller is not aware of any material nonpublic information and references Rule 10b5-1 procedures if applicable.

Insights

Securities Analyst

TL;DR: Small insider sale of 750 shares ($125,550) appears routine and immaterial relative to 212.7M shares outstanding.

The filing documents a routine Rule 144 notice for 750 shares acquired as restricted stock units on 10/23/2023 and scheduled for sale on 09/02/2025 through Morgan Stanley Smith Barney. Given the issuer's 212,677,178 shares outstanding, the transaction represents a de minimis percentage of the float and is unlikely to affect market valuation or signal major insider sentiment change. The statement affirming lack of material nonpublic information is standard; no prior three‑month sales were reported.

Corporate Governance Expert

TL;DR: Disclosure aligns with Rule 144 requirements and includes standard representations; no governance red flags evident.

The Form 144 provides required details: broker, share count, market value, acquisition method (RSUs), acquisition date, and planned sale date. The absence of recent insider sales and the explicit representation about material nonpublic information reduce immediate governance concerns. If the filer relied on a 10b5-1 trading plan, that date should be provided; its absence here simply reflects no plan date disclosed in this notice.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	750	125550.00	212677178	09/02/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/23/2023	Restricted Stock Units	Issuer			750	10/23/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the STX Form 144 report?

The filing reports a proposed sale of 750 shares of Seagate common stock with an aggregate market value of $125,550 via Morgan Stanley Smith Barney, dated for sale on 09/02/2025.

How and when were the shares acquired for this Form 144?

The 750 shares were acquired as Restricted Stock Units from the issuer on 10/23/2023.

Is this sale material relative to Seagate's shares outstanding?

No. The company has 212,677,178 shares outstanding, so 750 shares represent a de minimis portion and are not materially dilutive.

Did the filer report other sales in the past three months?

The filing states "Nothing to Report" under securities sold during the past three months.

Does the Form 144 indicate any undisclosed material information?

The filer explicitly represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.